New evidence for a role of melatonin in glucose regulation.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
melatonin | decrease | insulin secretion | pancreatic β-cells | - | interferes in this process by inhibiting | #1 |
melatonin | neutral | islets | - | - | transmitting circadian timing information | #2 |
melatonin | neutral | circadian insulin secretion | - | - | dependent synchronization | #3 |
melatonin | increase | melatonin levels | rats and mice | - | high during the dark period | #4 |
melatonin | increase | melatonin levels | humans | - | high during the overnight fasting and sleeping period | #5 |
melatonin | neutral | melatonin signaling | day-active species, including man | - | different read-out of melatonin signaling | #6 |
melatonin | neutral | insulin secretion | - | - | impact on insulin secretion transmitted through | #7 |
single nucleotide polymorphisms of the human MT2-receptor | increase | risk of developing T2D | - | - | causally linked with an elevated risk of developing | #8 |
Glucose triggers insulin secretion of the pancreatic β-cells. The pineal hormone melatonin interferes in this process by inhibiting secretion and transmitting circadian timing information to the islets. Circadian insulin secretion is adapted to day/night changes through melatonin-dependent synchronization. In rats and mice, melatonin levels are high during the dark period, which is their active feeding period, while, in humans, melatonin levels are high during the overnight fasting and sleeping period. This implies a different read-out of melatonin signaling in day-active species, including man. Dysregulation of circadian secretion may be a key to the increase of type 2 diabetes (T2D). This review discusses the impact of melatonin on insulin secretion transmitted through both the pertussis-toxin-sensitive membrane receptors MT1 (MTNR1a) and MT2 (MTNR1b) and the second messengers cAMP, cGMP and IP3. This is an important topic since, in several genetic association studies, single nucleotide polymorphisms of the human MT2-receptor have been described as being causally linked with an elevated risk of developing T2D. This article summarizes interrelationships between melatonin and insulin in type 1 diabetic (T1D) and type 2 diabetic (T2D) rats and humans.